Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Form 424B3 Cantor Fitzgerald Income
-
Vaxcyte to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023
-
Icosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023
-
BioVie to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
-
Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare Conference
-
Cantor Fitzgerald Starts Akero Therapeutics (AKRO) at Overweight, 'Positive on Upcoming F4 NASH Readout'
-
SELLAS Life Sciences to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
-
Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Danny Salinas Joins Cantor Fitzgerald as Chief Financial Officer
-
Jasper Therapeutics to Present at the Cantor Fitzgerald 2023 Global Healthcare Conference
-
CymaBay Announces Closing of Upsized $258.7 Million Public Offering of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Jazz Pharmaceuticals to Participate in Three Upcoming Investor Conferences
-
Cantor Fitzgerald and BGC Group Raise Spirits and Funds with Charity Day 2023
-
BGC Group and Cantor Fitzgerald Raise Spirits and Funds with Charity Day 2023
-
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
-
Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023
-
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Sanara MedTech to Participate in Two Upcoming Conferences
-
Cantor on Lyra Therapeutics (LYRA):'Better-Than-Expected BEACON Results Expand Opportunity for LYRA's CRS Platform'
-
Acelyrin (SLRN) crashes 60% as lead product misses in study; Seen as a 'big positive' for MoonLake (MLTX)
-
CymaBay Therapeutics (CBAY) Prices Upsized $225M Share and Warrant Offering at $17.13/sh
-
CymaBay Announces Pricing of Upsized $225 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Orchid Island Capital Announces September 2023 Monthly Dividend and August 31, 2023 RMBS Portfolio Characteristics
-
Mineralys Therapeutics to Participate in the Cantor Fitzgerald Global Healthcare Conference on Thursday, September 28, 2023
-
Artificial Intelligence-Driven Predictive Medical Diagnostics Company Spectral MD Announces Closing of Business Combination
-
Avertix to Present at Two Upcoming Investor Conferences in September 2023
-
CymaBay Therapeutics (CBAY) Announces Proposed $150M Share and Warrant Offering
-
CymaBay Announces Proposed $150 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Sprott Physical Uranium Trust Announces Updated “At-The-Market” Equity Program
-
Cantor Fitzgerald Starts Atossa Genetics (ATOS) at Overweight, 'Changing the Treatment Paradigm in Breast Cancer'
-
4DMT to Participate in Upcoming Investor Conferences
-
Cytokinetics to Participate in Upcoming Investor Conferences
-
Mustang Bio to Participate in Upcoming September 2023 Investor Conferences
-
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Form 8-K Cantor Fitzgerald Income For: Sep 06
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Daré Bioscience to Participate in Upcoming Investor Conferences
-
Rani Therapeutics to Participate in September Investor Conferences
-
Aston Bay Holdings Ltd. Announces C$5.0M Brokered Financing
-
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
-
Alkermes to Participate in Two Upcoming Investor Conferences
-
MIMEDX to Present at Upcoming Investor Conferences

